| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 283.853 | 255.487 | 268.681 | 324.892 | 360.991 | 459.336 | 481.857 | 552.345 | 474.775 | 476.629 |
| Total Income - EUR | 295.117 | 255.489 | 268.685 | 324.900 | 360.996 | 459.376 | 481.865 | 552.348 | 474.782 | 483.004 |
| Total Expenses - EUR | 287.994 | 256.649 | 264.289 | 304.033 | 331.930 | 413.925 | 434.831 | 511.873 | 456.139 | 483.923 |
| Gross Profit/Loss - EUR | 7.123 | -1.159 | 4.396 | 20.867 | 29.066 | 45.451 | 47.035 | 40.475 | 18.643 | -919 |
| Net Profit/Loss - EUR | 5.981 | -1.159 | 1.943 | 17.726 | 25.369 | 42.400 | 43.021 | 36.666 | 15.180 | -1.906 |
| Employees | 5 | 6 | 6 | 7 | 7 | 6 | 6 | 5 | 4 | 4 |
Check the financial reports for the company - Farmacia Melissa S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 14.368 | 13.376 | 11.586 | 9.838 | 17.661 | 13.676 | 10.724 | 37.120 | 25.308 | 38.169 |
| Current Assets | 61.045 | 62.168 | 77.183 | 89.918 | 77.752 | 92.135 | 130.988 | 148.396 | 112.931 | 107.723 |
| Inventories | 28.952 | 39.132 | 39.888 | 37.628 | 41.918 | 43.793 | 52.709 | 58.347 | 58.609 | 57.117 |
| Receivables | 30.100 | 12.395 | 30.952 | 40.346 | 31.387 | 41.229 | 40.509 | 77.580 | 41.975 | 45.791 |
| Cash | 1.993 | 10.640 | 6.342 | 11.944 | 4.447 | 7.113 | 37.770 | 12.469 | 12.347 | 4.815 |
| Shareholders Funds | 6.726 | 5.498 | 1.528 | 18.033 | 25.669 | 42.703 | 43.317 | 37.129 | 25.713 | 544 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 68.687 | 70.046 | 87.240 | 81.724 | 69.744 | 63.107 | 98.395 | 148.387 | 112.526 | 145.362 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Farmacia Melissa S.r.l.